These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 7479222)

  • 1. [Treatment of multiple myeloma associated anemia with human recombinant erythropoietin in a hemodialysis patient].
    Muszytowski M; Nowak J; Wojnicz M; Zalewska A; Ruszkiewicz-Fołda M
    Pol Arch Med Wewn; 1995 Jan; 93(1):77-9. PubMed ID: 7479222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and efficacy of recombinant human erythropoietin treatment of anaemia associated with multiple myeloma in haemodialysed patients.
    Ruedin P; Pechère Bertschi A; Chapuis B; Benedet P; Leski M
    Nephrol Dial Transplant; 1993; 8(4):315-8. PubMed ID: 8390005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant human erythropoietin in a patient with multiple myeloma and end-stage renal disease.
    Holley JL; Nolan TA; Piraino B
    Clin Nephrol; 1992 Mar; 37(3):145-7. PubMed ID: 1563119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant human erythropoietin in the treatment of multiple myeloma-associated anemia.
    Mittelman M; Zeidman A; Fradin Z; Magazanik A; Lewinski UH; Cohen A
    Acta Haematol; 1997; 98(4):204-10. PubMed ID: 9401498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Recombinant human erythropoietin in the treatment of the anemia of multiple myeloma with kidney failure].
    Arenas Gracia M; Abad Gosálvez A; Colomina Avilés J; Pascual Pérez R; Ferriz Moreno P
    An Med Interna; 1995 Apr; 12(4):187-8. PubMed ID: 7620064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant human erythropoietin in the anemia associated with multiple myeloma or non-Hodgkin's lymphoma: dose finding and identification of predictors of response.
    Cazzola M; Messinger D; Battistel V; Bron D; Cimino R; Enller-Ziegler L; Essers U; Greil R; Grossi A; Jäger G; LeMevel A; Najman A; Silingardi V; Spriano M; van Hoof A; Ehmer B
    Blood; 1995 Dec; 86(12):4446-53. PubMed ID: 8541533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erythropoietin treatment of anemia associated with multiple myeloma.
    Ludwig H; Fritz E; Kotzmann H; Höcker P; Gisslinger H; Barnas U
    N Engl J Med; 1990 Jun; 322(24):1693-9. PubMed ID: 2342535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transfusion and recombinant human erythropoietin requirements differ between dialysis modalities.
    House AA; Pham B; Pagé DE
    Nephrol Dial Transplant; 1998 Jul; 13(7):1763-9. PubMed ID: 9681725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Darbepoetin alfa effectively maintains haemoglobin concentrations at extended dose intervals relative to intravenous or subcutaneous recombinant human erythropoietin in dialysis patients.
    Brunkhorst R; Bommer J; Braun J; Haag-Weber M; Gill C; Wagner J; Wagener T;
    Nephrol Dial Transplant; 2004 May; 19(5):1224-30. PubMed ID: 14993489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The level of erythropoietin in patients with anemia and myeloma multiplex treated with erythropoietin].
    Ciepłuch H; Zaucha JM; Lysiak-Szydłowska W; Hellmann A
    Pol Arch Med Wewn; 1995 Aug; 94(2):153-8. PubMed ID: 8596750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum erythropoietin and creatinine concentrations as predictive factors for response to recombinant human erythropoietin treatment in anaemic tumour patients on chemotherapy.
    Fjornes T; Wiedemann GJ; Sack K; Jelkmann W
    Oncol Rep; 1998; 5(1):81-6. PubMed ID: 9458299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Recombinant human erythropoietin in the treatment of anemia associated with lymphoproliferative diseases--chronic lymphadenosis and multiple myeloma].
    Haber J; Spicka I; Petruzelka L; Kolesková E; Straub J; Jonásová A; Pospísilová B
    Vnitr Lek; 1996 Apr; 42(4):262-7. PubMed ID: 8693713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is erythropoietin treatment safe and effective in myeloma patients receiving hemodialysis?
    Caillette A; Barreto S; Gimenez E; Labeeuw M; Zech P
    Clin Nephrol; 1993 Sep; 40(3):176-8. PubMed ID: 8403574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of treatment of anemia with erythropoietin in patients with multiple myeloma].
    Adam Z; Krahulová M; Spelda S; Vorlícek J; Hejlová N; Hájek R; Tomíska M
    Vnitr Lek; 1995 Nov; 41(11):767-72. PubMed ID: 8553596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Does long-term erythropoietin therapy influence the prevalence of serum markers of hepatitis B and C in haemodialysed uraemic patients?].
    Mesjasz J; Wiecek A; Gonciarz Z; Mazur W; Kokot F
    Pol Merkur Lekarski; 2004 Apr; 16(94):362-7. PubMed ID: 15517934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of recombinant human erythropoietin (rHuEPO) on nutritional status of hemodialysis patients: investigation of direct anabolic effects of rHuEPO.
    Usuba T; Kuno T; Higuchi T; Kikuchi F; Nagura Y; Kanmatsuse K; Takahashi S
    Nihon Jinzo Gakkai Shi; 1994 Nov; 36(11):1288-95. PubMed ID: 7853762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of human erythropoietin derived from recombinant DNA on the anaemia of patients maintained by chronic haemodialysis.
    Winearls CG; Oliver DO; Pippard MJ; Reid C; Downing MR; Cotes PM
    Lancet; 1986 Nov; 2(8517):1175-8. PubMed ID: 2877323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant human erythropoietin treatment in cisplatin-associated anemia: a randomized, double-blind trial with placebo.
    Cascinu S; Fedeli A; Del Ferro E; Luzi Fedeli S; Catalano G
    J Clin Oncol; 1994 May; 12(5):1058-62. PubMed ID: 8164030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of recombinant human erythropoietin in the treatment of anaemia of prematurity.
    Polkowska G; Wójcik-Skierucha E; Furmaga-Jabłońska W
    Ann Univ Mariae Curie Sklodowska Med; 2004; 59(2):178-83. PubMed ID: 16146073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Erythropoietin treatment of tumor-associated anemia in patients with multiple myeloma].
    Ludwig H; Fritz E; Kotzmann H; Gisslinger H
    Onkologie; 1990 Feb; 13(1):46-9. PubMed ID: 2186325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.